Literature DB >> 12614761

Surgery for subfoveal choroidal neovascularization in toxoplasmic retinochoroiditis.

Alfredo Adán1, Carlos Mateo, Charlotte Wolley-Dod.   

Abstract

PURPOSE: To report a case of subfoveal choroidal neovascularization in a patient with toxoplasmic retinochoroiditis who underwent surgical excision.
DESIGN: Interventional case report.
METHODS: A 36-year-old woman with toxoplasmic retinochoroiditis presented with sudden dimness of vision and metamorphopsia in the left eye. The patient was examined with ophthalmoscopy and fluorescein angiography.
RESULTS: Fundus examination and fluorescein angiography of the left eye revealed a subfoveal choroidal neovascularization. Pars plana vitrectomy with submacular surgery was performed, with a postoperative improvement of visual acuity and resolution of the distortion.
CONCLUSIONS: This case report describes a case of subfoveal choroidal neovascularization associated with toxoplasmic retinochoroiditis that responded remarkably well to vitrectomy surgery. Copyright 2003 by Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12614761     DOI: 10.1016/s0002-9394(02)01947-5

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  Toxoplasmosis-associated neovascular lesions treated successfully with ranibizumab and antiparasitic therapy.

Authors:  Joseph D Benevento; Rama D Jager; A Gwendolyn Noble; Paul Latkany; William F Mieler; Mari Sautter; Sanford Meyers; Marilyn Mets; Michael A Grassi; Peter Rabiah; Kenneth Boyer; Charles Swisher; Rima McLeod
Journal:  Arch Ophthalmol       Date:  2008-08

2.  Intravitreal bevacizumab (Avastin) as primary and rescue treatment for choroidal neovascularization secondary to ocular toxoplasmosis.

Authors:  Salim Ben Yahia; Carl P Herbort; Salah Jenzeri; Kamel Hmidi; Sonia Attia; Riadh Messaoud; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2008-04-10       Impact factor: 2.031

3.  Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.

Authors:  Neeraj Pandey; Vandana Dwivedi
Journal:  Indian J Ophthalmol       Date:  2013-02       Impact factor: 1.848

4.  Intravitreal ranibizumab for the treatment of choroidal neovascularization secondary to ocular toxoplasmosis.

Authors:  Nikunj J Shah; Urmi N Shah
Journal:  Indian J Ophthalmol       Date:  2011 Jul-Aug       Impact factor: 1.848

5.  Coexisting choroidal neovascularization and active retinochoroiditis-an uncommon presentation of ocular toxoplasmosis.

Authors:  Sharat Hegde; Nidhi Relhan; Avinash Pathengay; Abhishek Bawdekar; Himadri Choudhury; Animesh Jindal; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2015-07-12

6.  Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor.

Authors:  Gaurav Mathur; Amala Elizabeth George; Parveen Sen
Journal:  Oman J Ophthalmol       Date:  2014-09

Review 7.  Pediatric uveitis: An update.

Authors:  Parthopratim Dutta Majumder; Jyotirmay Biswas
Journal:  Oman J Ophthalmol       Date:  2013-09

8.  Intravitreal aflibercept for choroidal neovascularization associated with chorioretinitis: a pilot study.

Authors:  Andrii R Korol; Oleksandra Zborovska; Taras Kustryn; Oleksandra Dorokhova; Nataliya Pasyechnikova
Journal:  Clin Ophthalmol       Date:  2017-07-20

Review 9.  An update on inflammatory choroidal neovascularization: epidemiology, multimodal imaging, and management.

Authors:  Aniruddha Agarwal; Alessandro Invernizzi; Rohan Bir Singh; William Foulsham; Kanika Aggarwal; Sabia Handa; Rupesh Agrawal; Carlos Pavesio; Vishali Gupta
Journal:  J Ophthalmic Inflamm Infect       Date:  2018-09-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.